Amrize AG (AMRZ)

Amrize AG is a common stock listed on the NYSE under the ticker AMRZ. The company provides building solutions for infrastructure, commercial, and residential construction markets in North America. Its operations are organized into two segments: Building Materials and Building Envelope. The Building Materials segment supplies cement, aggregates, ready-mix concrete, asphalt, and related construction materials. The Building Envelope segment focuses on roofing and wall system products, including single-ply membranes, insulation, shingles, sheathing, waterproofing, protective coatings, adhesives, tapes, and sealants. Amrize AG was incorporated in 2023 and is based in Zug, Switzerland. The company was formerly known as Holcim North America Finance Ltd and adopted the Amrize AG name in December 2013.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-AMRZ
$54.92
12.1% Upside
Fair
$63.16
28.9% Upside
Undervalued
Good
0.55
0.0%
August 6, 2026
23.5x
2.1x
2.3x
27.235 B
33.053 B
20.7%
89.1%
6.2
114.1%
Valuation • Fair Value

Amrize AG (NYSE-AMRZ) Fair Value by Valuation Model

Compare the primary fair value estimate for Amrize AG (NYSE-AMRZ) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$54.92

Estimated upside of 12.1% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$60.25

Discounted cash flow valuation reference.

Ben Graham Formula Value

$23.17

Classic Ben Graham valuation formula reference.

DDM Fair Value

$61.06

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$47.54

Comparable-company valuation reference.

Analyst Price Target

$63.16

Analysts imply upside of 28.9%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Amrize AG (NYSE-AMRZ) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Amrize AG (NYSE-AMRZ)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

11.912 B

Current operating scale indicator.

Revenue Forecast

12.422 B

Forward revenue estimate.

EBITDA

2.812 B

Current operating profitability reference.

EBITDA Forecast

3.258 B

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Amrize AG (NYSE-AMRZ) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Amrize AG (NYSE-AMRZ)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Good

Positive financial-health read.

Piotroski Score

4

Mid-range quality score.

Beneish M-Score

-2.64

No elevated caution signal from this screen.

Altman Z-Score

6.2

Relatively strong balance-sheet zone.

FCF / Net Income

114.1%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Amrize AG (NYSE-AMRZ). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Amrize AG (NYSE-AMRZ)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 6, 2026

Days to Earnings

16

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

0.55

Upcoming distribution amount.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

USD

Currency used for the distribution.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Amrize AG (NYSE-AMRZ), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Amrize AG (NYSE-AMRZ) Stock Forecast & Technical Outlook

Review Amrize AG (NYSE-AMRZ) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Sell

The 15-minute technical read for Amrize AG (NYSE-AMRZ) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Amrize AG (NYSE-AMRZ) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Amrize AG (NYSE-AMRZ) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Amrize AG (NYSE-AMRZ) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Neutral

The monthly technical read for Amrize AG (NYSE-AMRZ) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Amrize AG (NYSE-AMRZ)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Buy

Based on the available recommendation mix, Amrize AG (NYSE-AMRZ) has a Buy consensus, with 8 buy, 8 hold and 0 sell recommendations in the current data set.

Buy 8
Hold 8
Sell 0
FAQ Fast Investor Answers

Amrize AG (NYSE-AMRZ) Stock FAQ

Quick answers about Amrize AG (NYSE-AMRZ) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$54.92
Estimated upside 12.1%
Valuation Rating
Undervalued
Estimated upside of 12.1%
Analyst Target
$63.16
Implied upside 28.9%
Financial Health
Good
Current financial-health read

The current fair value estimate for Amrize AG (NYSE-AMRZ) is $54.92. This implies an estimated upside of 12.1% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 12.1% versus the current market price.

The available analyst price target for Amrize AG (NYSE-AMRZ) is $63.16. The analyst target implies estimated upside of 28.9%.

The current financial health read for Amrize AG (NYSE-AMRZ) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Amrize AG (NYSE-AMRZ) is August 6, 2026.

Based on the current data, dividend yield is 0.0%, upcoming dividend amount is 0.55.

The current P/E ratio listed for Amrize AG (NYSE-AMRZ) is 23.5x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Amrize AG is 27.235 B.

The current enterprise value listed for Amrize AG is 33.053 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Amrize AG is NYSE-AMRZ, and the stock is listed on NYSE.

Amrize AG (NYSE-AMRZ) is listed on NYSE.

The current debt-to-total-capital ratio listed for Amrize AG is 20.7%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Amrize AG is 89.1%. Free float helps investors understand how much of the share base is available for public trading.